2Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease : current status and new perspectives [ J]. Lancet Neurol, 2003, 2(9): 539 -547.
3Johannsen P. Long - term eholinesterase inhibitor treatment of Alzheimerg disease[J]. CNS Drugs, 2004, 18(12) : 757 -768.
4Sonkusare SK, Kaul CL, Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders - memantine, a new hope[J]. Pharmacol Res,2005, 51(1): 1 -17.
5Tariot PN, Farlow MR, Grossberg GT, et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial [ J ]. JAMA, 2004,291(3) : 317 -324.
2Tariot PN,Solomon PR,Morris JC,et al.A 5-month,randomized,placebo-controlled trial of galantamine in AD.The Galantamine USA-10 Study Group.Neurology,2000,54:2269-2276.
3Zhao Q,Xie C,Pesco-Koplowitz L,et al.Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil.J Clin Pharmacol,2003,43:180-186.
4Cummings JL.Alzheimer' s disease.N Engl J Med,2004,351:56-67.
5Zaudig M.A risk-benefit assessment of risperidone for the treatment of behavioral and psychological symptoms in dementia.Drug Saf,2000,23:183-195.
6Falsetti AE.Risperidone for control of agitation in dementia patients.Am J Health Syst Pharm,2000,57:862-870.
7Mintzer JE.Managing behavioral dyscontrol related to dementia.Primary Care Companion J Clin Psychitry,2003,5Suppl 6:14-21.
8De Deyn PP,Katz IR.Control of aggression and agitation in patients with dementia:efficacy and safety of risperidone.lnt J Geriatr Psychiatry,2000,15Suppl 1:S14-22.
9Doody RS,Stevens JC,Beck C,et al.Practice paraneter:management of dementia(an evidence-based review).Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2001,56:1154-1166.
10Orgogozo JM,Gilman S,Dartigues JF,et al.Subacute meningoencephalitis in a subset of patients with AD after Abeta42immunization.Neurology,2003,61:46-54.
